Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/9072
Title: Ligand-Based Virtual Screening and Molecular Docking of Two Cytotoxic Compounds Isolated From Papaver Lacerum
Authors: Bayazeid, Omer
Bedir, Erdal
Yalçın, Funda N.
Keywords: Papaver somniferum L.
Cytotoxicity
In silico analysis
Molecular docking
Publisher: Elsevier Ltd.
Abstract: This study revealed that the Papaver lacerum extract strongly inhibited HeLa cell proliferation, resulting in 13% cell viability. As a result of phytochemical studies, one known compound, Tyrosol-1-O-beta-xylopyranosyl-(1 -> 6)-O-beta-glucopyranoside) (I), and one new compound, 5-O-(6-O-alpha-rhamnopyronosyl-beta-glucopyronosyl) mevalonic acid (II), were isolated. Compounds I and II were found to possess a moderate cytotoxic effect with an IC50 of 66.4 mu M (p < 0.0001) and 54 mu M (p < 0.0001), respectively. The ligand-based virtual screening technique was used to reveal the possible molecular target of compounds I and II. The molecular target was identified as protein-tyrosine kinase Syk for compound I, and aldo-keto reductase family-1 for compound II. Molecular docking was used to assess the binding affinity of the compounds with the targets obtained from ligand-based virtual screening.
Description: WOS: 000461363900006
URI: https://doi.org/10.1016/j.phytol.2019.01.007
https://hdl.handle.net/11147/9072
ISSN: 1876-7486
1874-3900
Appears in Collections:Bioengineering / Biyomühendislik
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
1-s2.0-S1874390018306128-main.pdf2.43 MBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

8
checked on Dec 27, 2024

WEB OF SCIENCETM
Citations

7
checked on Dec 28, 2024

Page view(s)

726
checked on Dec 23, 2024

Download(s)

246
checked on Dec 23, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.